News > Page 22

• 

  Breakthrough Therapy for High-Risk Multiple Myeloma Shows Promising Results

  6/16/2024
• 

  Promising New CAR-T Therapy Targets Hard-to-Treat Multiple Myeloma

  6/15/2024
• 

  Takeda Joins Forces with Ascentage Pharma to Target Drug-Resistant Leukemia

  6/15/2024
• 

  FDA Greenlights Breakthrough Treatment for Aggressive Blood Cancer

  6/15/2024
• 

  New Leaps in Acute Leukemia Treatments: DSP-5336 Shows Promise

  6/15/2024
• 

  New Hope for Colon Cancer Patients: LIXTE's Innovative Trial with Roche and NKI

  6/14/2024
• 

  Groundbreaking Trial Enhances Outcomes for High-Risk Leukemia Patients

  6/14/2024
• 

  New Findings Highlight Earlier Use of Yescarta for Better Outcomes in Blood Cancer Treatment

  6/14/2024
• 

  New Antibody VYD222 Shows Promise Against Emerging COVID-19 Variants

  6/14/2024
• 

  Revumenib Shows Promise in Combating Acute Leukemias: Fresh Data from EHA 2024

  6/14/2024